v3.23.1
Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended 12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Apr. 30, 2022
Apr. 30, 2021
Cash flows from operating activities:        
Net loss $ (4,721,929) $ (2,775,124) $ (4,828,260) $ (2,452,170)
Adjustments to reconcile net loss to net cash used in operating activities        
Depreciation 20,090 20,070 26,566 32,967
Amortization       644
Amortization of debt discounts and deferred financing costs 61,381 33,954 156,719  
Stock-based compensation 149,153 118,249 68,396 24,675
Stock issued for note facility fee     35,000  
Warrants issued for note extensions     22,890  
Gain on settled accounts payable (81,200)      
Gain on extinguishment of debt   (250,200) (250,200) (250,200)
Loss on disposal of property and equipment       1,663
Changes in current assets and liabilities:        
Accounts receivable 2,321   (2,321)  
Inventory (2,770) 76,808 76,635 106,234
Prepaid and other current assets 270,387 (996) 72,524 20,972
Deferred offering costs 236,353 (230,760) (246,400)  
Accounts payable 427,142 62,318 358,964 (20,651)
Accrued liabilities (272,800) 493,859 865,343 83,572
Net cash used in operating activities (3,911,872) (2,451,822) (3,644,144) (2,452,294)
Cash flows from investing activities:        
Purchase of property and equipment (10,716) (1,932) (1,932) (712)
Net cash used in investing activities (10,716) (1,932) (1,932) (712)
Cash flows from financing activities:        
Proceeds from issuance of Series C preferred convertible stock, net of issuance costs       200,000
Issuance of Common Stock in IPO, net of fees 5,194,740      
Issuance of warrants in IPO 17,250      
Issuance of Common Stock for exercise of pre-funded warrants 14      
Proceeds from shareholder note   500,000 500,000 700,000
Proceeds from convertible promissory note       1,529,434
Proceeds from PPP loan       250,200
Proceeds from issuance of bridge convertible notes, net of discount   3,436,001 4,226,000  
Deferred financing costs   (377,520) (385,145)  
Repayment of shareholder note   (500,000) (500,000)  
Principal repayments of finance lease obligations (276,724)      
Net cash provided by investing activities 4,935,280 3,058,481 3,840,855 2,679,634
Net change in cash and cash equivalents during the period 1,012,692 604,727 194,779 226,628
Cash and cash equivalents, beginning of period 918,260 723,481 723,481 496,853
Cash and cash equivalents, end of period 1,930,952 1,328,208 918,260 $ 723,481
SUPPLEMENTAL DISCLOSURES OF NON-CASH TRANSACTIONS:        
Issuance of Common Stock for $1.5M Note conversions 1,500,000      
Issuance of Common Stock for Bridge Note and accrued interest conversions 3,618,704      
Issuance of Common Stock for Series A and B Preferred Stock conversions 703      
Issuance Of Common Stock for Series C Preferred Stock conversions 231      
Issuance of Common Stock warrants in connection with payable settlements   1,609    
Issuance of Common Stock warrants in connection with Bridge financing   $ 463,058 $ 555,767  
Warrants issued as underwriter compensation 39,953      
Financed insurance premiums 445,637      
Operating lease assets obtained in exchange for lease obligations $ 549,227